Literature DB >> 5542806

Decrease in adrenal tyrosine hydroxylase and increase in norepinephrine synthesis in rats given L-dopa.

W Dairman, S Udenfriend.   

Abstract

When large doses of L-dopa (1000 milligrams per kilogram, given subcutaneously) were administered to rats, the rate of catecholamine synthesis was increased in both the heart and adrenal gland. It is likely that increases also occur in other sympathetically innervated tissues. When the same dose of L-dopa was given daily for 4 or 7 days, the levels of tyrosine hydroxylase in the adrenal were lowered in comparison to controls. These findings may be a further indication of the existence of a regulatory mechanism which modifies endogenous levels of tyrosine hydroxylase in response to changes in the biosynthetic demand for norepinephrine.

Entities:  

Mesh:

Year:  1971        PMID: 5542806     DOI: 10.1126/science.171.3975.1022

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting.

Authors:  D M Yurek; K Steece-Collier; T J Collier; J R Sladek
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Ocular melanin and the adrenergic innervation to the eye.

Authors:  A M Laties
Journal:  Trans Am Ophthalmol Soc       Date:  1974

3.  Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

Authors:  A G Roberge; L J Poirier
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.

Authors:  J Lancaster; P R Sawyer; D M Shepherd; M J Turnbull
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

5.  Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.

Authors:  W Dairman
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.